TRACON Pharmaceuticals Announces Filing of Protocol for ENVASARC Pivotal Trial with the FDA

NEXT STORY
Chiesi publishes its annual report: Group generates almost €2 billion and obtains B Corp certification in 2019
PREV STORY
CalciMedica Announces Data Showing Auxora™ Substantially Improved Outcomes in Patients with Severe COVID-19 Pneumonia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Arbutus Biopharma Appoints Andrew Cheng, M.D., Ph.D., to its Board of Directors

author_avatar
NASDAQ Market News

Women’s Health Market Share, Growth Analysis, Global Trends, Industry Overview, Regional Forecast by 2026 | Top Leaders Eli Lilly and Company; Novartis AG; Pfizer Inc.; Merck & Co., Inc.; Novo Nordisk A/S; Amgen Inc.; Lupin Pharmaceuticals, Inc.

author_avatar
NASDAQ Market News

Junshi Biosciences Announces Two Additional Indications for Toripalimab Included in China’s National Reimbursement Drug List

author_avatar
NASDAQ Market News